Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04572451
Title Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jason J. Luke, MD
Indications

Advanced Solid Tumor

renal cell carcinoma

melanoma

Therapies

BMS-986253 + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.